World Heart Federation Roadmap on cardiac rehabilitation: a pathway to lifelong cardiovascular health

Julie Redfern1,2, Randal J Thomas3, Tom Briffa4

  • 1Institute for Evidence-Based Healthcare, Bond University, Robina, Queensland, Australia. jredfern@bond.edu.au.

Insights

This World Heart Federation Roadmap outlines strategies to improve lifelong cardiovascular health globally. It addresses key challenges in cardiac rehabilitation and secondary prevention for better patient outcomes and equitable care.

Area of Science:

  • Cardiology
  • Public Health
  • Health Policy

Background:

  • Aging populations and unhealthy lifestyles increase the burden of cardiovascular disease (CVD).
  • Cardiac rehabilitation has evolved to encompass comprehensive secondary prevention for lifelong cardiovascular health.
  • Healthcare systems face challenges in managing long-term CVD and its complications.

Purpose of the Study:

  • To present a united, forward-looking vision for global collaborative efforts in cardiovascular health.
  • To enhance equitable access to care, improve patient outcomes, and ensure value-based healthcare.
  • To outline interconnected solutions for lifelong cardiovascular health, addressing key roadblocks.

Main Methods:

  • Development of a World Heart Federation Roadmap.
  • Identification of five key roadblocks and widely applicable solutions.
  • Presentation of practical solutions and international case studies.

Main Results:

  • The roadmap emphasizes lifelong cardiovascular health, improved patient and clinician engagement, new care models, workforce strengthening, and policy advocacy.
  • Interlinked solutions are proposed to overcome identified roadblocks.
  • A shift towards systems thinking, policy, and advocacy is crucial for long-term investment.

Conclusions:

  • A unified, person-centered, and future-focused approach is essential for global cardiovascular health.
  • Implementation and evaluation strategies are needed for local and regional adoption of the roadmap.
  • Sustained investment in systems, policy, and advocacy is critical to meet growing demands for cardiovascular care.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...